Peritoneovenous shunt in malignant ascites. The Bordet Institute experience from 1975-1998.
This is the review of our experience in the treatment of malignant ascites using Le Veen and Denver peritoneovenous shunt. From 1975-1998, 24 peritoneovenous shunts were inserted in 22 patients with malignant ascites. All patients benefited from the procedure. The principal cause of failure was shunt occlusion (n = 5). This study permits us to conclude that a preoperative appropriated selection of patients, should decrease failure rate. Patients should be sent to surgery as soon as the diagnosis of recalcitrant ascites is confirmed, to obtain a longer and more comfortable quality of life with terminal cancer.